Skip to main content
ArticleOPEN ACCESS

Correction to: Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent (Breast Cancer Research, (2021), 23, 1, (25), 10.1186/s13058-021-01404-z)

Breast Cancer Research
DOI: 10.1186/s13058-021-01414-x
1Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

An amendment to this paper has been published and can be accessed via the original article.

Cite

CITATION STYLE

APA

Szucs, Z., Joseph, J., Larkin, T. J., Xie, B., Bohndiek, S. E., Brindle, K. M., & Neves, A. A. (2021, December 1). Correction to: Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent (Breast Cancer Research, (2021), 23, 1, (25), 10.1186/s13058-021-01404-z). Breast Cancer Research. BioMed Central Ltd. https://doi.org/10.1186/s13058-021-01414-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free